MLICM
ALPN

Metropolitan Life Insurance Company (MetLife)’s Alpine Immune Sciences Inc ALPN Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,027
Closed -$80.3K – 2279
2024
Q1 		$80.3K Buy
2,027
+284
+16% +$8.38K ﹤0.01% 1172
2023
Q4 		$33.2K Hold
1,743
– – ﹤0.01% 1650
2023
Q3 		$20K Hold
1,743
– – ﹤0.01% 1903
2023
Q2 		$17.9K Buy
1,743
+1,206
+225% +$10.9K ﹤0.01% 1993
2023
Q1 		$4.15K Sell
537
-881
-62% -$7.02K ﹤0.01% 2280
2022
Q4 		$10.4K Buy
+1,418
New +$9.06K ﹤0.01% 2271

Metropolitan Life Insurance Company (MetLife)'s ALPN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 2,027 shares — an estimated $80.3K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ALPN in Q4 2022 and held it in 6 quarters. The position peaked at $80.3K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,027 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $80.3K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Alpine Immune Sciences Inc in Q4 2022 and held it in 6 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Alpine Immune Sciences Inc position peaked at $80.3K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.